Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
68.34
+0.61 (0.90%)
At close: Oct 8, 2025, 4:00 PM EDT
68.45
+0.11 (0.16%)
After-hours: Oct 8, 2025, 6:43 PM EDT
Hologic Revenue
Hologic had revenue of $1.02B in the quarter ending June 28, 2025, with 1.23% growth. This brings the company's revenue in the last twelve months to $4.04B, up 1.29% year-over-year. In the fiscal year ending September 28, 2024, Hologic had annual revenue of $4.03B, down -0.00%.
Revenue (ttm)
$4.04B
Revenue Growth
+1.29%
P/S Ratio
3.87
Revenue / Employee
$571,839
Employees
7,063
Market Cap
15.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 28, 2024 | 4.03B | -100.00K | -0.00% |
| Sep 30, 2023 | 4.03B | -832.40M | -17.12% |
| Sep 24, 2022 | 4.86B | -769.50M | -13.66% |
| Sep 25, 2021 | 5.63B | 1.86B | 49.14% |
| Sep 26, 2020 | 3.78B | 409.10M | 12.15% |
| Sep 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 24, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 26, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
HOLX News
- 6 days ago - Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025 - Business Wire
- 6 days ago - Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis - Business Wire
- 8 days ago - New Survey Results Underscore the Need to #BustTheMyth About Mammograms - Business Wire
- 9 days ago - Volition Signs Co-Marketing and Services Agreement with Hologic - PRNewsWire
- 9 days ago - Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm - PRNewsWire
- 12 days ago - New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI - Business Wire
- 21 days ago - Blackstone and TPG revive interest in buying Hologic, source says - Reuters
- 4 weeks ago - Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha